Advocacy intelligence hub — real-time data for patient organizations
Shanghai Jiao Tong University School of Medicine — PHASE3
Instituto de Investigacion Sanitaria La Fe
Purixan: FDA approved
Treatment of patients with acute lymphoblastic leukemia as part of a combination regimen.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs2
TAFINLAR
Novartis Pharmaceuticals Corp.
Purixan
Nova Laboratories Limited
Browse all Acute myeloblastic leukemia with maturation news →
B. Smith, M.S.W., L.C.S.W
Johns Hopkins University
📍 OKLAHOMA CITY, OK
Kyoo H. Lee, MD
Asan Medical Center
Colleen Delaney, MD
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
📍 OLD GREENWICH, CT
Sucha Nand, MD
SWOG Cancer Research Network
📍 MAYWOOD, IL
Jeffrey Lancet, MD
Moffitt Cancer Center
📍 TAMPA, FL
Maria Baer
Cancer and Leukemia Group B
View all Acute myeloblastic leukemia with maturation specialists →